subject area of
- A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia Journal Articles
- AAV-mediated expression of 3TSR inhibits tumor and metastatic lesion development and extends survival in a murine model of epithelial ovarian carcinoma Journal Articles
- ABT-898 Induces Tumor Regression and Prolongs Survival in a Mouse Model of Epithelial Ovarian Cancer Journal Articles
- Addition of an Fc-IgG induces receptor clustering and increases the in vitro efficacy and in vivo anti-tumor properties of the thrombospondin-1 type I repeats (3TSR) in a mouse model of advanced stage ovarian cancer Journal Articles
- Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation Journal Articles
- Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial Journal Articles
- Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer Journal Articles
- Circulating Inflammation Markers and Risk of Epithelial Ovarian Cancer Journal Articles
- Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation Journal Articles
- Dalteparin Low Molecular Weight Heparin (LMWH) in ovarian cancer: A phase II randomized study Journal Articles
- FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper Journal Articles
- Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors Journal Articles
- Hyperglycemia promotes insulin-independent ovarian tumor growth Journal Articles
- Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer Journal Articles
- Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer Journal Articles
- Muscle weakness and mitochondrial stress occur before severe metastasis in a novel mouse model of ovarian cancer cachexia Journal Articles
- Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo Journal Articles
- Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer Journal Articles
- Orthotopic, syngeneic mouse model to study the effects of epithelial-stromal interaction Journal Articles
- Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer Journal Articles
- Phase 2 study evaluating intermittent and continuous linsitinib and weekly paclitaxel in patients with recurrent platinum resistant ovarian epithelial cancer Journal Articles
- Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I Journal Articles
- Practice guidelines for BRCA1/2 tumour testing in ovarian cancer Journal Articles
- Role of trypsin and protease-activated receptor-2 in ovarian cancer. Journal Articles
- Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition Journal Articles
- Temporal trends in the relative survival among patients diagnosed with ovarian cancer in Canada 1992–2005: A population-based study Journal Articles
-
The risks of breast and ovarian cancer associated with the Ashkenazi Jewish founder allele
BRCA2 6174delT Journal Articles - Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers Journal Articles
- Weight Gain and the Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers Conferences